Circulating Tumor-reactive CD8(+) T cells in melanoma patients contain a CD45RA(+)CCR7(-) effector subset exerting ex vivo tumor-specific cytolytic activity.

Détails

ID Serval
serval:BIB_F07737704ACD
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Circulating Tumor-reactive CD8(+) T cells in melanoma patients contain a CD45RA(+)CCR7(-) effector subset exerting ex vivo tumor-specific cytolytic activity.
Périodique
Cancer Research
Auteur(s)
Valmori D., Scheibenbogen C., Dutoit V., Nagorsen D., Asemissen A.M., Rubio-Godoy V., Rimoldi D., Guillaume P., Romero P., Schadendorf D., Lipp M., Dietrich P.Y., Thiel E., Cerottini J.C., Liénard D., Keilholz U.
ISSN
0008-5472
Statut éditorial
Publié
Date de publication
2002
Peer-reviewed
Oui
Volume
62
Numéro
6
Pages
1743-1750
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't Publication Status: ppublish
Résumé
To defend the host from malignancies, the immune system can spontaneously raise CD8(+) T-cell responses against tumor antigens. Investigating the functional state of tumor-reactive cytolytic T cells in cancer patients is a key step for understanding the role of these cells in tumor immunosurveillance and for evaluating the potential of immunotherapeutic approaches of vaccination against cancer. In this study we identified a subset of circulating tumor-reactive CD8(+) T lymphocytes, which specifically secreted IFN-gamma after exposition to autologous tumor cell lines in stage IV metastatic melanoma patients. Additional phenotypic characterization using multicolor flow cytometry revealed that a significant fraction of these cells were CD45RA(+)CCR7(-), a phenotype that has been proposed recently to characterize cytolytic effectors potentially able to home into inflamed tissues. In the case of an HLA-A2-expressing patient, the antigen specificity of this population was identified by using HLA-A2/peptide multimers incorporating a tyrosinase-derived peptide. Consistently with their phenotypic characteristics, A2/tyrosinase peptide multimer(+) CD8(+) T cells, isolated by cell sorting, were directly lytic ex vivo and able to specifically recognize tyrosinase-expressing tumor cells. Overall, these results provide the first evidence that a proportion of melanoma patients have circulating tumor-reactive T cells, which are lytic effectors cells.
Mots-clé
Antigens, CD45/blood, Antigens, CD45/immunology, CD8-Positive T-Lymphocytes/cytology, CD8-Positive T-Lymphocytes/immunology, Cytotoxicity, Immunologic, Epitopes, T-Lymphocyte/immunology, HLA-A2 Antigen/immunology, Humans, Lymphocyte Activation/immunology, Melanoma/blood, Melanoma/immunology, Monophenol Monooxygenase/immunology, Receptors, CCR7, Receptors, Chemokine/blood, Receptors, Chemokine/immunology, T-Lymphocyte Subsets/immunology, T-Lymphocyte Subsets/metabolism, T-Lymphocytes, Regulatory/cytology, T-Lymphocytes, Regulatory/immunology
Pubmed
Web of science
Création de la notice
28/01/2008 12:14
Dernière modification de la notice
20/08/2019 17:18
Données d'usage